Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection

被引：4
|
作者：
Einsiedel, Hagen Graf [1 ]
Christiansen, Holger [1 ]
Wiegand, Johannes [2 ]
机构：
[1] Univ Leipzig, Abt Padiat Onkol Hamatol & Hamostaseol, Leipzig, Germany
[2] Univ Leipzig, Klin & Poliklin Gastroenterol & Rheumatol, Sekt Hepatol, Liebigstr 20, D-04103 Leipzig, Germany
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2016年 / 35卷 / 12期
关键词：
D O I：
10.1097/INF.0000000000001336
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1373 / 1373
页数：1
相关论文
共 50 条
  • [41] Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection
    Sundaram, Vinay
    Kowdley, Kris V.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (01) : 13 - 20
  • [42] Sofosbuvir for Chronic Hepatitis C Virus Infection Genotype 1-4 in Patients Coinfected With HIV
    Rodriguez-Torres, Maribel
    Gaggar, Anuj
    Shen, Gong
    Kirby, Brian
    Svarovskaia, Evguenia
    Brainard, Diana
    Symonds, William T.
    McHutchison, John G.
    Gonzalez, Milagros
    Rodriguez-Orengo, Jose
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 543 - 549
  • [43] The effectiveness and safety of sofosbuvir-ledipasvir for patients with hepatitis C virus genotype 2 infection
    Chen, Po-Yueh
    Yang, Hsin-Yi
    Chou, Chu-Kuang
    Chang, Li-Jen
    Hsu, Ming-Tse
    Tsai, Tsung-Jung
    Fang, Chien-Chung
    Su, Chang-Chao
    Lin, Yu-Ling
    Feng, Yu-Ming
    Chen, Chi-Yi
    ADVANCES IN DIGESTIVE MEDICINE, 2022, 9 (02) : 91 - 97
  • [44] SOFOSBUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION
    Temesgen, Z.
    Talwani, R.
    Rizza, S. A.
    DRUGS OF TODAY, 2014, 50 (06) : 421 - 434
  • [45] Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
    Younossi, Z. M.
    Park, H.
    Saab, S.
    Ahmed, A.
    Dieterich, D.
    Gordon, S. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (06) : 544 - 563
  • [46] Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis
    Tao, Tingting
    Jiang, Xuehua
    Chen, Yuehong
    Song, Yiran
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 55 : 56 - 71
  • [47] Safety and Efficacy of 8-weeks Ledipasvir/Sofosbuvir Combination in Chronic Hepatitis C Genotype 4-Infected Patients
    Babatin, Mohamed
    Alghamdi, Abdullah S.
    Assiri, Abdullah
    Aleladi, Haziz
    Shoja, Hamad
    Mogharbel, Mohaammed
    Alsahafi, Ashwaq
    Mahalawi, Wadad
    Sanai, Faisl
    HEPATOLOGY, 2017, 66 : 821A - 821A
  • [48] Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years
    Behairy, E. Behairy
    El-Araby, Hanaa A.
    El-Guindi, Mohamed A.
    Basiouny, Hosam-Eldin M.
    Fouad, Ola A.
    Ayoub, Bassam A.
    Marei, Ayman M.
    Sira, Mostafa M.
    JOURNAL OF PEDIATRICS, 2020, 219 : 106 - 110
  • [49] Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Stoehr, Albrecht
    Gauthier, Aline
    Atanasov, Petar K.
    Petersen, Joerg
    HEPATOLOGY, 2015, 62 : 806A - 806A
  • [50] US Experience of Sofosbuvir plus Ledipasvir plus Ribavirin for 12 Weeks in Previous Treatment Experienced Genotype 1 Chronic Hepatitis C With Cirrhosis
    Hermann, John E.
    Gonzalez, Stevan
    Gautam, Manjushree
    Ashfaq, Mohammad
    Modi, Apurva A.
    GASTROENTEROLOGY, 2016, 150 (04) : S1106 - S1106
12345